• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Annovis Bio Inc (NY: ANVS )

    5.310 -0.200 (-3.63%)
    Official Closing Price Updated: 7:00 PM EDT, Jun 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 223,458
    Open 5.800
    Bid (Size) 5.320 (6)
    Ask (Size) 5.460 (20)
    Prev. Close 5.510
    Today's Range 5.310 - 5.850
    52wk Range 4.790 - 22.49
    Shares Outstanding 11,171,480
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Officials to Present Results from Alzheimer’s Study at AAIC 2024
    Via Investor Brand Network
    BioMedNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Results of Recent Alzheimer’s Study, Schedules Investor Call
    Via Investor Brand Network

    Performance

    YTD
    -71.95%
    -71.95%
    1 Month
    -39.31%
    -39.31%
    3 Month
    -40.47%
    -40.47%
    6 Month
    -52.16%
    -52.16%
    1 Year
    -64.88%
    -64.88%

    More News

    Read More
    Annovis Bio Inc. (NYSE: ANVS) Is ‘One to Watch’
    Via Investor Brand Network
    Peering Into Annovis Bio's Recent Short Interest
    Via Benzinga
    BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Event Spotlighting Lead Drug Candidate
    Via Investor Brand Network
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Annovis Announces New Publication in a Peer-Reviewed Journal
    From Annovis Bio Inc.
    Via GlobeNewswire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
    From Law Offices of Frank R. Cruz
    Via Business Wire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    ANVS Stock Earnings: Annovis Bio Beats EPS for Q1 2024
    Via InvestorPlace
    Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results
    From Annovis Bio Inc.
    Via GlobeNewswire
    Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
    From Annovis Bio Inc.
    Via GlobeNewswire
    Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
    From Annovis Bio Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    S&P 500 Edges Higher; ON Semiconductor Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Alzheimer's-Focused Annovis Bio Stock Nosediving On Monday?
    Via Benzinga
    Stocks Quietly Climb Ahead Of Central Bank Storm
    Via Talk Markets
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease
    From Annovis Bio Inc.
    Via GlobeNewswire
    ANVS Stock Earnings: Annovis Bio Misses EPS for Q4 2023
    Via InvestorPlace
    Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
    From Annovis Bio Inc.
    Via GlobeNewswire
    Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.